Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Plus Finasteride After SCI
NCT02248701Phase 2Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Apr 2017
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of testosterone enanthate in Hypogonadism, sponsored by VA Office of Research & Development. Started Apr 2017; status: terminated.
02
Drugs
testosterone enanthate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT02248701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02248701.